Copyright ©2012 Baishideng. All rights reserved.
World J Hematol. Jun 6, 2012; 1(1): 1-4
Published online Jun 6, 2012. doi: 10.5315/wjh.v1.i1.1
An exciting time to launch the World Journal of Hematology
Xiaoyan Jiang
Xiaoyan Jiang, Department of Medical Genetics, University British Columbia, Terry Fox Laboratory, BC Cancer Agency, 675 West 10th Avenue, Vancouver, BC, V5Z 1L3, Canada
Author contributions: Jiang X solely contributed to this paper.
Correspondence to: Xiaoyan Jiang, MD, PhD, Associate Professor, Senior Scientist, Department of Medical Genetics, University of British Columbia, Terry Fox Laboratory, BC Cancer Agency, 675 West 10th Avenue, Vancouver, BC, V5Z 1L3, Canada. xjiang@bccrc.ca
Telephone: +1-604-6758141 Fax: +1-604-8770712
Received: April 13, 2012
Revised: April 28, 2012
Accepted: May 3, 2012
Published online: June 6, 2012

This first issue of the World Journal of Hematology (WJH) marks the birth of a new member of the World Series Journal family and comes at one of the most exciting times in stem cell biology and translational medicine. The pace of discovery in the field of hematology has accelerated signeificantly in recent years, due to important scientific discoveries and new technologies for purification of hematopoietic stem cells and identification of specific stem cell biomarkers; whole genome sequencing using next-generation sequencing technology; and development of molecularly-targeted therapies, leading to the translation of highly promising science into advanced diagnosis and proven targeted therapies for hematopoietic disorders. The WJH is an open-access, peer-reviewed journal, which is officially published on June 6, 2012. The WJH Editorial Board consists of 102 experts in hematology from 26 countries. There is clearly a niche for this new journal, which provides access to all articles without boundaries to all internet users throughout the world. The WJH aims to provide rapid access to high impact publications in fundamental and clinical hematology, with multidisciplinary coverage, through an established system that is targeted at dissemination to the scientific community via online open-access.

Keywords: Hematology, Biomedical sciences, Translational medicine, Stem cell biology, Next-generation sequencing, Molecular targeted therapies, Tyrosine kinase inhibitors, Chronic myeloid leukemia, Acute promyelocytic leukemia, Peer-reviewed, Open-access, Journal